We have located links that may give you full text access.
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study.
Nephrology, Dialysis, Transplantation 2009 January
BACKGROUND: Chronic kidney disease (CKD) is associated with increased mortality in patients with heart failure (HF). However, its association with hospitalization in HF patients has not been well studied.
METHODS: Of 7788 patients in the Digitalis Investigation Group trial, 3527 had CKD, defined by an estimated glomerular filtration rate (GFR) <60 ml/min/1.73 m(2) body surface area (BSA). Propensity scores for CKD were calculated using a multivariable logistic regression model and used to match 2399 pairs of patients with and without CKD. Matched Cox regression analyses were used to estimate association of CKD with outcomes.
RESULTS: All-cause hospitalization occurred in 1636 (rate, 4233/10,000 person-years) and 1587 (rate, 3733/10,000 person-years) patients respectively, with and without CKD (matched hazard ratio [HR] for CKD, 1.18, 95% confidence interval [CI], 1.08-1.29; P < 0.0001). Matched HR for cardiovascular and HF hospitalization were respectively 1.17 (95% CI, 1.06-1.28, P = 0.002) and 1.28 (95% CI, 1.13-1.45, P < 0.0001). Compared to GFR >or=60 ml/min/1.73 m(2) BSA, HR for all-cause hospitalization for GFR 45-59 and <45 ml/min/1.73 m(2) BSA were respectively 1.04 (95% CI, 0.94-1.16; P = 0.422) and 1.58 (95% CI, 1.34-1.87; P < 0.0001). Similarly, HR for all-cause death for GFR 45-59 and <45 ml/min/1.73 m(2) BSA were respectively 1.03 (95% CI, 0.90-1.18; P = 0.651) and 1.70 (95% CI, 1.40-2.07; P < 0.0001). Matched HR for death due to cardiovascular causes and progressive HF were respectively 1.24 (95% CI, 1.09-1.40; P = 0.001) and 1.42 (95% CI, 1.16-1.72; P = 0.001).
CONCLUSION: CKD was associated with increased mortality and hospitalization in ambulatory patients with chronic HF, which increased progressively with worsening kidney function.
METHODS: Of 7788 patients in the Digitalis Investigation Group trial, 3527 had CKD, defined by an estimated glomerular filtration rate (GFR) <60 ml/min/1.73 m(2) body surface area (BSA). Propensity scores for CKD were calculated using a multivariable logistic regression model and used to match 2399 pairs of patients with and without CKD. Matched Cox regression analyses were used to estimate association of CKD with outcomes.
RESULTS: All-cause hospitalization occurred in 1636 (rate, 4233/10,000 person-years) and 1587 (rate, 3733/10,000 person-years) patients respectively, with and without CKD (matched hazard ratio [HR] for CKD, 1.18, 95% confidence interval [CI], 1.08-1.29; P < 0.0001). Matched HR for cardiovascular and HF hospitalization were respectively 1.17 (95% CI, 1.06-1.28, P = 0.002) and 1.28 (95% CI, 1.13-1.45, P < 0.0001). Compared to GFR >or=60 ml/min/1.73 m(2) BSA, HR for all-cause hospitalization for GFR 45-59 and <45 ml/min/1.73 m(2) BSA were respectively 1.04 (95% CI, 0.94-1.16; P = 0.422) and 1.58 (95% CI, 1.34-1.87; P < 0.0001). Similarly, HR for all-cause death for GFR 45-59 and <45 ml/min/1.73 m(2) BSA were respectively 1.03 (95% CI, 0.90-1.18; P = 0.651) and 1.70 (95% CI, 1.40-2.07; P < 0.0001). Matched HR for death due to cardiovascular causes and progressive HF were respectively 1.24 (95% CI, 1.09-1.40; P = 0.001) and 1.42 (95% CI, 1.16-1.72; P = 0.001).
CONCLUSION: CKD was associated with increased mortality and hospitalization in ambulatory patients with chronic HF, which increased progressively with worsening kidney function.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app